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Autophagy is a fundamental homeostatic process in which cytoplasmic targets are sequestered within double-membraned
autophagosomes and subsequently delivered to lysosomes for degradation. Accumulating evidence supports the pivotal role
of autophagy in host defense against intracellular pathogens implicating both innate and adaptive immunity. Many of these
pathogenscausecommonzoonoticinfectionsworldwide.Theinductionoftheautophagicmachinerybyinnateimmunereceptors
signaling, such as TLRs, NOD1/2, and p62/SQSTM1 in antigen-presenting cells results in inhibition of survival and elimination
of invading pathogens. Furthermore, Th1 cytokines induce the autophagic process, whereas autophagy also contributes to antigen
processing and MHC class II presentation, linking innate to adaptive immunity. However, several pathogens have developed
strategies to avoid autophagy or exploit autophagic machinery to their advantage. This paper focuses on the role of host cell
autophagy in the regulation of immune response against intracellular pathogens, emphasizing on selected bacterial and protozoan
zoonoses.
“Let your food be your medicine and your medicine your food”
—Hippocrates, 460-377 BC
1.Introduction
The term autophagy etymologically originates from the
Greek “auto”, meaning oneself, and “phagy”, meaning to eat.
Macroautophagy (hereafter simply referred to as autophagy)
is a dynamic biological process in which various cyto-
plasmic targets are sequestered within double-membraned
vesicles, called autophagosomes, and subsequently delivered
to lysosomes for degradation. It constitutes an evolutionarily
conserved, intracellular mechanism between all eukaryotes
for the maintenance of cellular homeostasis. Although, at
basal, constitutive level, autophagic activity is usually low, it
is markedly upregulated in response to cell stress, nutrient
starvation, and immunological stimuli [1, 2].
Recently, substantial evidence demonstrates the pivotal
role of autophagy in host defense against infections impli-
cating both innate and adaptive immunity. In particular, the
induction of the autophagic machinery in macrophages is an
importantinnateimmunemechanismresultingininhibition
of survival and direct, through degradation (xenophagy) or
indirect, viaformation and release of antimicrobial peptides,
elimination of various intracellular pathogens [3]. Ligation
of pathogen-associated molecular patterns (PAMPs) with
pattern recognition receptors (PRRs)resultsin the activation
of autophagy [4, 5]. Conversely, autophagy contributes to
the delivery of PAMPs to endosomal PRRs indicating a
bidirectional relationship between autophagy and innate
immune receptors [6]. In addition, several cytokines and
reactive oxygen species (ROS) that are released during the
immune response to infection have been found to trigger the
autophagic process [5, 7, 8].
Notably, autophagy contributes to antigen processing
and facilitates major histocompatibility complex (MHC)
class II and probably I presentation, linking innate to adap-
tive immune mechanisms [1, 9]. Additionally, autophagy in-
directly inﬂuences the adaptive immunity against microbes
by regulating the development and survival of lymphocytes
[1, 9]. Finally, autophagy is an eﬀector of Th1 immune2 Clinical and Developmental Immunology
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Figure 1:Theinterplaybetweenautophagyandintracellularpathogens.Pathogenengulfmentbyantigenpresentingcells(e.g.,macrophage)
and PRRs (TLR, NOD, p62) signaling induce the initiation of autophagic machinery (Ukl1/2 and PI3K-Beclin1-Atg14 complex) and
the formation of autophagosome (LC3B II), resulting in pathogen elimination by autolysosomal degradation (e.g., Salmonella). Th1
immune rensponse (IFNγ) further enhances the autophagic process. In parallel, autophagic pathway intersects the endosomal network and
targets microbial antigens of phagocytosed pathogens to MHC II loading compartment (MIIC), promoting endogenous MHC II antigen
presentation. Zoonotic intracellular pathogens juxtapose diﬀerent mechanisms to manipulate autophagy aiming to survival and chronic
parasitism, such as block (e.g., Brucella) or delay (e.g., Coxiella) of autophagolysosomal fusion, inhibition of the initiation of the autophagic
machinery(e.g.,cytoplasmic Listeria)and induction ofautophagy in order toreceive nutritionsupplies (e.g., Toxoplasma). Redlines indicate
negative eﬀect. ER; endoplasmic reticulum, Ub; ubiquitin, CV; containing vacuoles, PV; parasitophorous vacuoles.
response, which is critical for the eradication of many
intracellular microbes [7].
On the other hand, several intracellular pathogens
have developed diverse evasion strategies against autophagy
or exploit autophagic machinery, aiming to establish an
intracellular niche for long-term survival and replication
[10]. Many of these pathogens are responsible for common
zoonotic infections, representing an important cause of
morbidityandmortalityworldwide.Thisreviewsummarizes
the role of host cell autophagy in the regulation of immune
response against intracellular pathogens, emphasizing on
bacterial and protozoan zoonotic infections.
2. Basics of the Autophagic Molecular Pathway
The autophagic pathway is unreeled in three principal stages:
initiation, elongation, and maturation. Yeast genetic studies
haveidentiﬁedmorethan30autophagy-relatedgenes(ATG),
which are responsible for the triggering and regulation of
autophagic machinery, although the mammalian homologs
are not completely identiﬁed yet [7].
At the initiation stage, the autophagosome begins to
form as isolation membrane (phagophore), originating from
rough endoplasmic reticulum or probable by other mem-
brane sources such as Golgi apparatus, mitochondria,
plasma, or nuclear membrane [2, 3]( Figure 1). Atg1 (Ulk1/2
for mammals) induces this step in cooperation with a key
molecular complex that constitutes class III phosphatidyli-
nositol 3 kinase (PI3K) hVPS34 in association with Beclin
1 (homolog of Atg6) and Atg14. Mammalian target of
rapamycin (mTOR) protein kinase is thought to be the mas-
ter endogenous regulator of autophagy. mTOR is coupled to
Ulk1/2 complex (Ulk1/2-Atg13-FIP200-Atg101) inhibiting
the induction of autophagic machinery in a nutrient-de-
pendent manner (Figure 1). Upon nutrient/energy starva-
tion, mTOR dissociates from the Ulk1/2 complex, which
translocates at early, preautophagosomal structures exerting
its inductive eﬀect. Rapamycin is a well-characterized inhibi-
tor of mTOR and is commonly used for the in vitro induc-
tion of autophagy [11]. In addition, the binding of Bcl-2
antiapoptotic protein to Beclin 1 disrupts the association of
Beclin 1 with hVPS34, leading to the inhibition of autophagy
[12].
During the next step of elongation, isolation membrane
enlarges and closes to form the double-membraned autoph-
agosomethatenwrapsthecytoplasmictarget(Figure 1).This
process is regulated by two ubiquitin-like conjugation sys-
tems that are activated by Atg7, which is essential for both
of them: (a) the Atg16/Atg5-Atg12 complex, which results
from the Atg16 (Atg16L in mammals) in association with
the Agt5-Atg12 conjugate and (b) the LC3B system which isClinical and Developmental Immunology 3
the human homolog of yeast Atg8. Speciﬁcally, Atg16/Atg5-
Atg12 complex acts as E3-like enzyme of the ubiquitin
system and induces the LC3B I lipidation with phosphati-
dylethanolamine, resulting in LC3B II generation. LC3B-II-
lipidated protein is translocated at nascent autophagosomal
membrane facilitating its growth, expansion, and closure
[2, 11]( Figure 1). Finally, after autophagosomal maturation
to autolysosome, LC3B undergoes lysosomal degradation.
Thus, LC3 II is a tracker of autophagosomes and the con-
version of LC3 I to LC3 II is a widely used marker to monitor
autophagic activity [13].
However, it has been recently suggested an Atg5/Atg7-
independent alternative pathway of the mammalian auto-
phagy that seems to be regulated by Ulk1and Beclin 1 and
generates autophagosomes in a Rab9-dependent manner by
the fusion of isolation membranes with vesicles derived from
the trans-Golgi and late endosomes [14].
Maturation represents the ﬁnal, degradative, step of au-
tophagicmolecularpathwaywhentheautophagosomesloose
the inner of the two membranes and fuse with late endoso-
mal/lysosomal organelles, to form autolysosomes. Autolyso-
somes are single-membraned, acidic, vacuoles assigned to
degrade sequestered material by lysosomal hydrolases [11]
(Figure 1). Maturation depends on the molecular complex
consisting of hVPS34—Beclin 1 in association with UVRAG
(VPS38). UVRAG is a positive regulator of autophagic mat-
uration activating Rab7 GTPase, a key element for the bio-
genesis and maintenance of the lysosomal compartment [15,
16]. Noteworthy, during maturation autolysosomes can also
fuse with antigen processing and major histocompatibility
complex (MHC) class II loading compartments, support-
ing MHC-II restricted endogenous antigen presentation
(Figure 1)[ 17].
3. Autophagy andImmuneResponse to
IntracellularPathogens
The interplay between intracellular pathogens and host
immune system is critical for the development of chronic
parasitism or infection clearance. Five years ago, the term
“immunophagy” was introduced to cumulatively describe
the contribution of autophagic machinery to all aspects
of immunity. In fact, autophagy possesses regulatory and
effector role inﬂuencing immune response against intracel-
lular pathogens in many diﬀerent ways [18]. The established
role of autophagy as an in vivo defense mechanism against
intracellular bacteria and protozoa has been demonstrated
by studies using Atg5 knockout mice infected by Listeria
and Toxoplasma, two well-characterized zoonotic pathogens
[19, 20].
3.1. Antigen-Presenting Cells, PRRs, and Autophagy. Ma-
crophages of the reticuloendothelial system are activated
by autophagy (autophagic macrophage activation, APMA)
in order to properly modulate intracellular microenviron-
ment and combat the invading pathogens [10]. Autophagic
elimination of intracellular microbes by APMA implicates
two main ways: xenophagy and release of neoantimicrobial
peptides [3, 10].
The best studied and well characterized is xenophagy,
where microbes undergo direct degradation by autolyso-
somes. In contrast to nonselective or bulk autophagy that
induced by nutrient deprivation or rapamycin, xenophagy
involves autophagic adaptors/receptors for selective degra-
dation of foreigner invaders [21]. This process is triggered
by innate immunity receptors (PRRs), such as Toll-like re-
ceptors(TLRs)andnucleotide-binding,oligomerization-do-
main-(NOD-)like receptors (NLRs), following the detection
of various PAMPs on cellular surface or into cytosol
(Figure 1). Almost all members of the TLR family are
thought to be directly or indirectly involved in the initiation
and regulation of autophagic machinery against intracellular
pathogens [3]. In most of these studies, the model of myco-
bacterial infection has been used. For example, TLR4 stim-
ulation by lipopolysaccharide (LPS) induces autophagy in
macrophages enhancing mycobacterium colocalization with
the autophagosomes [22]. It seems that TLR4 signaling me-
diates the recruitment of Beclin-1 through dissociation
of Bcl-2 inhibitor, promoting autophagy [23]. Moreover,
TLR2/1 signaling regulates antibacterial autophagy pathway
through functional vitamin D3 receptor activation and ca-
thelicidin expression [24], while induction of autophagy in
BCG-infected macrophages by TLR7 ligands results in path-
ogen elimination in a MyD88-dependent manner [25]. Of
note, it is suggested that autophagy induction downstream
of TLRs activation is balanced by the inhibitory eﬀect of NF-
κB[ 26], although this matter seems to be under controversy
recently [27].
Ontheotherhand,autophagyactsupstreamtoPRRsand
mediates the delivery of microbial sensors to cytosolic recep-
tors. This process is probably related to viral infections, given
that ssRNA recognition of endosomal TLR7 and production
of interferon-α (IFNα) by plasmacytoid dendritic cells are
suggested to be autophagy dependent [6].
Recent evidence also links bacterial sensing by cytoplas-
mic NLRs with the induction of autophagy. It is proposed
that NOD1/2 signaling recruits Atg16L1 to plasma mem-
brane at the sites of bacterial entry [28]. Dendritic cells
from individuals with Crohn’s disease that express NOD2 or
Atg16L1 risk variants perform defective autophagy [29]. In-
terestingly, Atg16L1 polymorphism has been recently asso-
ciated with an excessive production of IL-1β and IL-6 in
humans, further indicating the implication of autophagy in
the pathophysiology of Crohn’s disease [30]. Together these
ﬁndings support a potential role of food-borne enterobacte-
rial infections in Crohn’s disease’s pathogenesis.
Sequestosome-like receptors (SLRs) represent a new
group of cytoplasmic PRRs, which serve as adaptors for
selective autophagy. In particular, SLRs contain an LC3 in-
teracting region (LIR), commissioned to recognize and cap-
ture ubiquitin-coated intracellular microbes or microbes-
containing compartments for xenophagy (Figure 1). SLRs
contribute to xenophagy against zoonotic bacteria such as
Salmonella and Listeria [2].
Besides the active role of xenophagy in host defense as
a “microbial killer”, several lines of evidence also indicate
its regulatory role as an “immune recognition enhancer” of
host infected cells via the generation of antigenic microbial4 Clinical and Developmental Immunology
peptides. It is well established that autophagic pathway
intersects the endosomal network and targets microbial
antigensofphagocytosedpathogenstoMHCIIloadingcom-
partment, promoting MHC II presentation to CD4+ T-
lymphocytes (Figure 1)[ 17]. Dendritic cells that lack key
autophagy proteins such as Atg5, Atg7, or Atg16L1 are char-
acterized by disturbances of the MHC II presentation
pathway [9]. Studies of Mycobacterium have demonstrated
that rapamycin-induced autophagy enhances MHC II pre-
sentation by mouse dendritic cells and increases antigen
speciﬁc CD4+ T-cells [31]. In addition, NOD2-mediated
autophagy is required for the generation of MHC II antigen-
speciﬁc CD4+ T cell responses in human dendritic cells
[29]. Interestingly, recent studies, albeit limited, suggest the
implication of autophagic machinery to MHC I presentation
of phagocytosed pathogens [32, 33]. These results support
the speculation that autophagy facilitates antigenic cross-
presentation process, which is critical in promoting CD8+
T-cell responses to bacteria and virus [34].
In another way of autophagic clearance, antimicro-
bial peptides are generated, via a process that implicates
p62/SQSTM1 SLR. Ribosomal proteins and ubiquitin are
delivered to proteolysis in autolysosomes where they are pro-
teolytically converted into potent neoantimicrobial peptides
(cryptides), further reinforcing host immune arsenal [3].
These peptides exert their antibacterial activity following the
fusion of autolysosomes with parasitophorous phagosomes.
Although this microbicidal mechanism has been demon-
strated for M. tuberculosis, it is also probably related to
various other intracellular bacteria like L. monocytogenes, S.
typhimurium [35].
Moreover, during the APMA, phagocytosis and autopha-
gy pathway are interconnected in a process that involves
TLRs engagement and signaling. Phagocytosis constitutes a
fundamentalantimicrobialmechanismwherebytheengulfed
microbe is targeted to specialized endocytic compartments,
the phagosomes, and delivered to lysosomes for degradation.
Translocation of Beclin 1 and LC3 to the phagosome is
related to phagosome-lysosome fusion, leading to acidiﬁca-
tion and killing of the ingested organism [36].
3.2. Cytokines and Autophagy Regulation. Several cytokines
modulateautophagicmechanismstolimitintracellularpath-
ogens replication and disturb their lifestyle. In particular,
Th1 immune response is thought to be critical in host pro-
tection against intracellular pathogens, while Th2 switch
has been associated with the establishment of chronicity.
Of note, the principal Th1 cytokine IFNγ induces the au-
tophagic control of M. tuberculosis, whereas Th2 cytokines
(IL-4, IL-13) yield an inhibitory eﬀect [37]. Experimental
studies on macrophages have demonstrated the implication
of activating immunity related GPTases (IRGs) in the au-
tophagic clearance of diﬀerent intracellular pathogens [3].
Apart from the induction of the autophagic machinery,
IRGs also promote the expression of host defense proteins,
such as the phagocyte oxidase, and antimicrobial peptides
[38]. In mouse, various IRGs (Irgm1, Igrm3, Irga6) are
directly induced by IFNγ (IFN-γ-inducible GTPases), con-
ferring immunity to diﬀerent intracellular infections within
macrophages and animals [20, 39, 40]. In human, IRGM
is the only IRG that has been identiﬁed since today [3].
Although it is not directly IFNγ inducible, it is important for
the autophagic elimination of mycobacteria upon stimula-
tion of macrophages by IFNγ [41]. Moreover, human genetic
studies have demonstrated the association between IRGM
single nucleotide polymorphisms (SNPs) and predisposition
to tuberculosis, further underscoring the role of autophagy
in intracellular bacterial infection [42–44].
TNFα is another Th1 cytokine, which strongly enhances
the bactericidal activity of macrophages. TNFα has been
also reported to upregulate autophagy in a ROS-dependent
manner,althoughthiseﬀectwasdemonstratedintumorcells
that lack NF-κBa c t i v i t y[ 26]. In addition, TNFα stimulates
p62/SQSTM1-mediated autophagic activity and restricts the
survival of Shigella and Listeria [45].
Furthermore, type I interferons have been implicated in
antiviral autophagic response both in vitro and in vivo [46,
47]. Moreover, treatment of macrophages with interleukin
IL-1triggerstheubiquitinationofBeclin1andtheformation
of autophagosomes [48].
4. The CrosstalkbetweenAutophagy and
Zoonotic Pathogens
Previous data strongly support the role of autophagy as
an immune mechanism in the defense against intracellular
pathogens. However, many pathogens successfully survive
and replicate inside antigen-presenting cells (macrophages,
dendritic cells) using diﬀerent strategies to subvert innate
immunity. Some intracellular pathogens parasitize in surviv-
al-permitting special phagosomes by remodeling the intra-
cellularcompartment to prevent phagosome maturation and
phagolysosome fusion. Other intracellular microorganisms
escape into the cytoplasm to avoid lysosomal degradation. A
third evasion mechanism includes evasion from autophagic
machinery or diversion from phagosomal to autophagic
pathway and manipulation of host autophagy for microbial
survival and replication [49].
Hereinafter, the role of host autophagy in zoonoses is
described using selected examples of common bacterial and
protozoan infections.
4.1. Salmonella: Autophagy Targets Enterobacterial Pathogens
withZoonoticPotential. Worldwide,foodbornediseases,and
more especially diarrhoeal diseases, constitute an important
cause of morbidity and mortality. S. Typhimurium is one of
themostvirulentfoodborne pathogenscausinggastroenteri-
t i si nh u m a n s[ 50].
S. Typhimurium invades nonphagocytic cells, such as
epithelialcellsandlocalizeswithinamembrane-boundcom-
partmentcalledSalmonella-containingvacuole(SCV)where
thebacteriumreplicates,protectedfromtheimmunesystem.
However, some of the SCVs are damaged and cytosolic-
evaded bacteria can subsequently be targeted by ubiquitin
system for autophagy [51]. Knockdown of mouse embryonic
ﬁbroblastforAtg5wasassociatedwithincreasedintracellular
bacterial growth, suggesting a role for autophagy in prevent-
ing bacterial escape into the cytoplasm and restricting itsClinical and Developmental Immunology 5
survival [49]. However, the in vivo role of xenophagy against
Salmonella infection has been demonstrated in experimental
models using autophagy defective parasites. Mutations in
autophagy genes rendered these parasites susceptible to S.
Typhimurium lethal infection, allowing intracellular sur-
vival and replication [52]. Recent studies report that the
autophagic adapters p62/SQSTM1 and NDP52 are involved
in the autophagic clearance of ubiquitin-coated Salmonella
from the cytosol [53, 54]. It has been also demonstrated that
phosphorylation of the autophagy receptor optineurin via
TBK1 kinase restricts Salmonella intracellular growth [55].
In macrophages, S. Typhimurium SipB bacterial protein
activates the autophagic machinery, causing autophagic cell
death through the disruption of mitochondria [56]. This
process might represent a host defense mechanism that
destroys the bacterial intracellular cycle or, in contrast, it
could be a bacterial virulence strategy [57].
4.2. Listeria: Inhibition of Autophagic Machinery Favors
Survival. L. monocytogenes is a Gram-positive facultative an-
aerobe bacterium that causes febrile enteritis and invasive
listeriosis, a disease that occurs primarily in newborn in-
fants, pregnant women, elderly, and immunocompromised
patients. Listeriosis is associated with a high mortality rate
especially when complicated with sepsis and central nervous
systeminvolvement.ThemainrouteofacquisitionofListeria
is the ingestion of contaminated food products such as raw
meat, dairy products, vegetables, and seafood [58].
L. monocytogenes,i nc o n t r a s tt oSalmonella, replicates in
the cytoplasm after escaping from the phagosome. For this
purpose, Listeria secretes listeriolysin O (LLO) toxin which
forms pores on the phagosome membrane. Listeria has been
shown to induce autophagic response in ﬁbroblasts, epithe-
lial cells, and macrophages in the early phase of primary
infection [59, 60]. Furthermore, bacterial expression of LLO
was required for autophagy induction [60, 61]. A recent
study using macrophages and gene-deﬁcient animals sup-
ports the role of IFNγ-inducible IRGs to cell-autonomous
immunity and autophagy response to listerial infection [38].
However, Listeria has developed sophisticated mecha-
nisms to escape from the autophagic machinery elimination.
Speciﬁcally, ActA virulence protein, which is responsible for
the actin-based motility of Listeria, has been shown to pro-
tect the bacterium from autophagic degradation. ActA pro-
motes the recruitment of host cytosolic actin polymerization
components (Arp2/3, Ena/VASP and actin) to properly mask
pathogen from the recognition of ubiquitin-p62/SQSTM1-
LC3 autophagic system (Figure 1),whe r easA ctAm u tantsar e
eﬃciently targeted by selective autophagy [62]. In addition,
NDP52 autophagic adaptor has also been reported to target
Listeria ActA mutant, further indicating the crucial role of
ActA in resistance to the autophagic machinery [45].
Noteworthy, a second “camouﬂage” strategy has been
recently demonstrated in L. monocytogenes murine infec-
tion. Listeria internalin InlK recruits major vault protein
(MVP), a mammalian cytoplasmic protein, which disguises
intracytosolic bacteria from ubiquitination and autophagic
recognition promoting survival [63]( Figure 1).
4.3. Brucella: Block of (Auto)Phagolysosomal Fusion for
Chronic Parasitism. Brucellosis is the commonest bacterial
zoonotic infection worldwide. Brucella infects humans by
consumption of contaminated dairy products or by occupa-
tional contact with infected animals. In humans, the disease
causes high clinical morbidity and protean clinical manifes-
tations, as any organ may be aﬀected. Brucella can survive
andreplicateforprolongedperiodswithinhostmacrophages
and dendritic cells, producing chronic, and even lifelong,
infections. To achieve this, Brucella produces various viru-
lence factors, such as smooth LPS and outer membrane pro-
teins/lipoproteins (Omps) that modify phagocytosis, pha-
golysosome fusion, antigen presentation, cytokine secretion,
and apoptosis [64].
Brucella containing vacuoles (BCV) are special tight pha-
gosomes, which represent the intracellular replication com-
partments. The type IV secretion system (T4SS) is a mem-
brane-associated transporter used to deliver substrate mol-
ecules to target cells. Brucella T4SS is crucial for the devel-
opment of the BCV in host cells as it has been described to
modify the bacterial intracellular traﬃcking [65].
The participation of autophagy in Brucella spp. intra-
cellular traﬃcking remains a matter of controversy [66]. In
the epithelial cell line HeLa, B. abortus can be found in
autophagosomes-like BCVs, supporting the hypothesis that
pathogenic B. abortus exploits the autophagic machinery to
establish an intracellular replication niche within the en-
doplasmic reticulum [67]. However, autophagic BCVs were
not detected in murine macrophages [68]. Moreover, studies
in cultured human peripheral blood monocytes did not
demonstrate any association between BCVs and rough en-
doplasmic reticulum or autophagosomes, even though BCVs
avoid fusion with lysosomes [69]( Figure 1).
4.4.Coxiella:TheAutophagolysosomalFusionDelaystoBeneﬁt
Survival. C. burnetii is an obligate intracellular pathogen
that causes Q fever, a worldwide zoonose with acute and
chronic stages, ranging from asymptomatic to fatal disease.
Farm animals and pets are the main reservoirs of infection,
although a variety of species may be infected. Infection of
humans usually occurs via inhalation of contaminated aero-
solsbydriedplacentalmaterial,ﬂuids,andexcretaofinfected
animals [70].
Once C. burnetii is internalized by the host cell, it is
localized in early phagosomes which fuse with other vesicles
to form the large parasitophorous vacuoles (PV) where
this pathogen multiplies [49]. Early engagement of the au-
tophagic machinery in the PV was associated with a delay
in lysosomal fusion that enables C. burnetii to replicate
(Figure 1). This process closely depends on T4SS virulence
factor, although its eﬀectors have not been identiﬁed yet
[71, 72]. In addition, recent ﬁndings indicate that C. burnetii
infection modulates autophagy and apoptotic pathways
through Beclin 1/Bcl-2 interplay to establish a persistent in-
fection in host cell. It seems that both PV development
and the antiapoptotic eﬀect of C. burnetii on host cells are
aﬀected by Beclin 1 depletion and by the expression of a
Beclin 1 mutant defective in Bcl-2 binding [73].6 Clinical and Developmental Immunology
4.5. Toxoplasma and Leishmania: The Autophagic Machin-
ery against Protozoa. Toxoplasmosis is a zoonotic parasitic
disease caused by the protozoan T. gondii. Toxoplasmosis is
found in humans and in many species of animals worldwide.
Cats are the primary source of infection to human hosts and
fecal contamination of hands by Toxoplasma oocysts is a sig-
niﬁcant risk factor. Other routes of human infection include
ingestion of undercooked meat and consumption of con-
taminated food or drink. The majority of primary infections
produce no symptoms in immunocompetent persons; how-
ever,congenitaltoxoplasmosismayresultinprematurebirth,
hydrocephalus, chorioretinitis, deafness, or epilepsy [74].
Several lines of evidence indicate the role of autophagy
in defense against T. gondii. In particular, CD40, a member
of the TNF-receptor superfamily, signaling has been found
to trigger autophagy, inducing macrophage anti-Toxoplasma
gondiiactivity[75].Moreover,Portilloetal.usedToxoplasma
murine model to demonstrate the in vivo role of CD40-
autophagic machinery for host resistance independently of
IFN-γ. CD40 signaling upregulates Beclin 1 and triggers
the elimination of T. gondii in microglia/macrophages by
decreasing protein levels of p21, a molecule that degrades
Beclin 1. These ﬁndings suggest CD40-p21-Beclin 1 as a
pathway by which adaptive immunity stimulates autophagy
[76]. Other animal studies also support the in vivo role of
IFN-γ-inducible IRGs and ATg5 in autophagic host response
against toxoplasma [20, 40].
Interestingly, a recent study presents evidence that Atg5-
associated autophagic induction by T. gondii in HeLa cells
and primary ﬁbroblasts is independent of mTOR signaling,
suggesting that T. gondii derives nutritive beneﬁt from the
upregulation of host cell autophagy to promote its intracel-
lular growth [77]. Collectively these data probably indicate a
dual role of host cell autophagy to T. gondii infection, acting
either as a defense or as a protective mechanism (Figure 1).
Leishmania is an intracellular protozoan parasite that
invades macrophages in the dermis after inoculation. Cuta-
neous leishmaniasis is the most common form of leishmani-
asis, whereas visceral leishmaniasis is a severe form in which
the parasites have migrated to the vital organs [78].
L. donovani promastigotes survive and evolve into
amastigotes in phagolysosomes. Subsequently, amastigotes
multiply and disseminate to the reticulo-endothelial system
through vascular and lymphatic system, inﬁltrating the bone
marrow macrophages. It is thought that the inhibition of
autophagolysosome formation potentiates the survival of
this parasite. Induction of autophagy by IFNγ or starvation
increasedL.amazonensisloadandthepercentagesofinfected
macrophages from BALB/c but not from C57BL/6 mice,
suggesting that autophagy may regulate the outcome of
L. amazonensis infection in macrophages in a host strain
speciﬁc manner [79]. Moreover, we have also reported the
induction of the autophagic machinery during natural hu-
man bone marrow infection by L. donovani [78].
5. Conclusions
Autophagy is an important host cell defense mechanism
against intracellular pathogens; many of them character-
ized by zoonotic potential and cause persistent/relapsing
infections. The involvement of autophagy in both innate
and adaptive immunity to infections is well established. On
the other hand, several pathogens have evolutionary devel-
oped antiautophagic strategies or manipulate autophagic
machinery for their own beneﬁt to achieve survival and/or
chronic parasitism. Further elucidation of the autophagic
mechanisms implicated in the immune response or the cross
talkbetween theimmune systemand pathogensis important
for the discovery of biomarkers, concerning infection relapse
and chronicity, as well as development of novel, autophagy-
based, therapeutic approaches and vaccination strategies in
livestock and humans [80].
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